Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012931
Filing Date
2018-05-10
Accepted
2018-05-10 16:01:24
Documents
42
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gern-10q_20180331.htm 10-Q 1579466
2 EX-31.1 gern-ex311_8.htm EX-31.1 17403
3 EX-31.2 gern-ex312_9.htm EX-31.2 17423
4 EX-32.1 gern-ex321_6.htm EX-32.1 7631
5 EX-32.2 gern-ex322_7.htm EX-32.2 7617
  Complete submission text file 0001564590-18-012931.txt   5625576

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gern-20180331.xml EX-101.INS 1466200
7 XBRL TAXONOMY EXTENSION SCHEMA gern-20180331.xsd EX-101.SCH 26940
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gern-20180331_cal.xml EX-101.CAL 28762
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gern-20180331_def.xml EX-101.DEF 91155
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20180331_lab.xml EX-101.LAB 236805
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20180331_pre.xml EX-101.PRE 165634
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1117
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 18822354
SIC: 2834 Pharmaceutical Preparations